EGFR and prostate carcinoma: EGFR is a type-I transmembrane glycoprotein that is involved in cell growth and differentiation.(6) Overexpression of EGFR is observed in many cancers, including head and neck, lung, colorectal, breast, pancreatic, kidney, ovary, bladder, and prostate cancers.(7)